GILEAD SCIENCES, INC

GILD
Real-time Estimate Quote. Real-time Estimate  - 11/25 05:04:59 pm
60.25USD 0.00%
Upcoming events on GILEAD SCIENCES, INC.
12/05/20 | 10:00am American Society of Hematology Meeting - Abstract No -#1646
12/05/20 | 10:00am American Society of Hematology Meeting - Abstract No -#1120
12/05/20 | 10:00am American Society of Hematology Meeting - Abstract No -#1224
12/05/20 | 10:00am American Society of Hematology Meeting - Abstract No -#1145

Past events on GILEAD SCIENCES, INC.
10/30/20BioNJ C-Suite Summit
10/28/20 | 03:30pmQ3 2020 Earnings Call
10/28/20 | 03:01pmQ3 2020 Earnings Release
10/21/20IDWeek Virtual Conference - Oral No - 103

Upcoming sector events for GILEAD SCIENCES, INC.
11/26/20 | 02:00am HANGZHOU TIGERMED CONSULTING CO.,LTD : Extraordinary Shareholders Meeting
12/01/20 GALAPAGOS NV : Investor Meeting - Kempen
12/01/20 | 03:55pm DENALI THERAPEUTICS INC. : Evercore ISI HealthCONx Conference
12/01/20 ARGENX SE : Piper Sandler Health Care Conference

Past sector events for GILEAD SCIENCES, INC.
11/24/20QIAGEN N.V. : Kempen Benelux Conference
11/24/20GALAPAGOS NV : Kempen Benelux Conference
11/23/20 | 04:30pmARROWHEAD PHARMACEUTICALS, INC. : FY 2020 Earnings Call
11/23/20ARROWHEAD PHARMACEUTICALS, INC. : FY 2020 Earnings Release

Annual results
Previous yearNext Year
Annual results20192020 (e)
Sales
M $
Released
Forecast
Spread
22 449
22 305
0,65%

23 650
Operating income
(EBITDA)
M $
Released
Forecast
Spread
12 468
13 029
-4,3%

12 633
Operating profit
(EBIT)
M $
Released
Forecast
Spread
11 064
11 571
-4,4%

11 163
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
5 160
5 333
-3,2%

1 465
Net income
M $
Released
Forecast
Spread
5 386
4 292
26%

34,3
EPS
$
Released
Forecast
Spread
4,22
3,43
23%

-0,01
Announcement Date02/04/2020


Quarterly / Semiannualy publications
Previous periodNext period
Quarterly results2020 Q32020 Q4 (e)
Sales
M $
Released
Forecast
Spread
6 577
6 303
4,3%

6 422
Operating income
(EBITDA)
M $
Released
Forecast
Spread
3 807
3 688
3,2%

3 797
Operating profit
(EBIT)
M $
Released
Forecast
Spread
3 452
3 130
10%

3 008
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
825
1 844
-55%

1 521
Net income
M $
Released
Forecast
Spread
360
1 577
-77%

1 349
EPS
$
Released
Forecast
Spread
0,29
1,25
-77%

1,07
Announcement Date10/28/2020

Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise